N Engl J Med. 2008 Jun 19;358(25):2704-15. doi: 10.1056/NEJMra072739.

Cancer immunology.

Source

Department of Immunology, University of Pittsburgh School of Medicine, E1044, Biomedical Science Tower, Pittsburgh, PA 15261, USA. ojfinn@pitt.edu

Comment in

Cancer immunotherapy. [N Engl J Med. 2008]
Cancer immunotherapy.Rosenberg SA, Dudley ME, Restifo NP. N Engl J Med. 2008 Sep 4; 359(10):1072.
Cancer immunotherapy--the endgame begins. [N Engl J Med. 2008]
Cancer immunotherapy--the endgame begins.Weiner LM. N Engl J Med. 2008 Jun 19; 358(25):2664-5.

PMID:: 18565863; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Cancer - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Review Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy. [Cancer Immunol Immunother. 2009]
Review Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy.
Baxevanis CN, Perez SA, Papamichail M. Cancer Immunol Immunother. 2009 Mar; 58(3):317-24. Epub 2008 Aug 15.
From therapeutic monoclonal antibodies to therapeutic vaccines for cancer. [Hum Vaccin. 2009]
From therapeutic monoclonal antibodies to therapeutic vaccines for cancer.
Berinstein NL. Hum Vaccin. 2009 Jun; 5(6):364-7.
Tumor immunology top 10 list. [Immunol Rev. 2008]
Tumor immunology top 10 list.
Finn OJ. Immunol Rev. 2008 Apr; 222:5-8.
Review Cancer immunotherapy. [Biotechnol J. 2006]
Review Cancer immunotherapy.
Schuster M, Nechansky A, Kircheis R. Biotechnol J. 2006 Feb; 1(2):138-47.
Review Cancer immunotherapy: a treatment for the masses. [Science. 2004]
Review Cancer immunotherapy: a treatment for the masses.
Blattman JN, Greenberg PD. Science. 2004 Jul 9; 305(5681):200-5.

See reviews... See all...

Cited by 91 PubMed Central articles

Tumor Inhibition by DepoVax-Based Cancer Vaccine Is Accompanied by Reduced Regulatory/Suppressor Cell Proliferation and Tumor Infiltration. [ISRN Oncol. 2013]
Tumor Inhibition by DepoVax-Based Cancer Vaccine Is Accompanied by Reduced Regulatory/Suppressor Cell Proliferation and Tumor Infiltration.
Karkada M, Quinton T, Blackman R, Mansour M. ISRN Oncol. 2013; 2013:753427. Epub 2013 Mar 7.
Chitin, chitosan, and glycated chitosan regulate immune responses: the novel adjuvants for cancer vaccine. [Clin Dev Immunol. 2013]
Chitin, chitosan, and glycated chitosan regulate immune responses: the novel adjuvants for cancer vaccine.
Li X, Min M, Du N, Gu Y, Hode T, Naylor M, Chen D, Nordquist RE, Chen WR. Clin Dev Immunol. 2013; 2013:387023. Epub 2013 Mar 4.
What is recent in pancreatic cancer immunotherapy? [Biomed Res Int. 2013]
What is recent in pancreatic cancer immunotherapy?
Niccolai E, Prisco D, D'Elios MM, Amedei A. Biomed Res Int. 2013; 2013:492372. Epub 2012 Dec 26.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Cancer immunology.
Cancer immunology.
N Engl J Med. 2008 Jun 19 ;358(25):2704-15. doi: 10.1056/NEJMra072739.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: